Systematic review of the role of cytoreductive nephrectomy in the targeted therapy era and beyond: an individualized approach to metastatic renal cell carcinoma
B Bhindi, EJ Abel, L Albiges, K Bensalah, SA Boorjian… - European urology, 2019 - Elsevier
Context The role of cytoreductive nephrectomy (CN) in the management of metastatic renal
cell carcinoma (mRCC) in the targeted therapy (TT) era is controversial. Objective To assess …
cell carcinoma (mRCC) in the targeted therapy (TT) era is controversial. Objective To assess …
Individualised indications for cytoreductive nephrectomy: which criteria define the optimal candidates?
Context The current role of cytoreductive nephrectomy (CN) is controversial. Objective
Review of the available evidence about criteria defining CN optimal candidates. Evidence …
Review of the available evidence about criteria defining CN optimal candidates. Evidence …
Survival analyses of patients with metastatic renal cancer treated with targeted therapy with or without cytoreductive nephrectomy: a national cancer data base study
Purpose The role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma
(mRCC) has become unclear since the introduction of targeted therapies (TT). We sought to …
(mRCC) has become unclear since the introduction of targeted therapies (TT). We sought to …
Should CARMENA really change our attitude towards cytoreductive nephrectomy in metastatic renal cell carcinoma? A systematic review and meta-analysis …
F Massari, V Di Nunno, L Gatto, M Santoni… - Targeted Oncology, 2018 - Springer
Background Cytoreductive nephrectomy in metastatic renal cell carcinoma (mRCC) patients
has been common clinical practice due to evidence that resection of the primary tumor …
has been common clinical practice due to evidence that resection of the primary tumor …
Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features
R Mathieu, G Pignot, A Ingles, M Crepel, P Bigot… - … Oncology: seminars and …, 2015 - Elsevier
Objectives The role of cytoreductive nephrectomy (CN) in the treatment of patients harboring
metastatic renal cell carcinoma (mRCC) has become controversial since the emergence of …
metastatic renal cell carcinoma (mRCC) has become controversial since the emergence of …
Cytoreductive nephrectomy in metastatic renal cell carcinoma treated with targeted therapies: a systematic review with a meta-analysis
F Petrelli, A Coinu, I Vavassori, M Cabiddu… - Clinical genitourinary …, 2016 - Elsevier
Cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC)(resection of the
primary tumor for debulking purposes) was considered to be an important part of oncological …
primary tumor for debulking purposes) was considered to be an important part of oncological …
The role of cytoreductive nephrectomy: European Association of Urology recommendations in 2016
A Bex, B Ljungberg, H van Poppel, T Powles… - European urology, 2016 - Elsevier
Patient summary After the introduction of systemic targeted therapies, the use of
nephrectomy in patients with metastatic renal cell carcinoma has declined. Currently …
nephrectomy in patients with metastatic renal cell carcinoma has declined. Currently …
Clinical correlates and prognostic value of different metastatic sites in metastatic renal cell carcinoma
O Abdel-Rahman - Future Oncology, 2017 - Taylor & Francis
Aim: Real life data on the clinical correlates and prognostic value of metastatic sites in
metastatic renal cell carcinoma (RCC) are needed. This parameter was assessed in RCC …
metastatic renal cell carcinoma (RCC) are needed. This parameter was assessed in RCC …
Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting
T Klatte, K Fife, SJ Welsh, M Sachdeva… - World Journal of …, 2018 - Springer
Purpose To test the hypothesis that cytoreductive nephrectomy (CN) improves overall
survival (OS) of patients with synchronous metastatic renal cell carcinoma (mRCC), who …
survival (OS) of patients with synchronous metastatic renal cell carcinoma (mRCC), who …
The association between cytoreductive nephrectomy and overall survival in metastatic renal cell carcinoma with primary tumor size≤ 4 cm
S Tappero, F Barletta, ML Piccinelli, CC Garcia… - European Urology …, 2023 - Elsevier
Background It is unknown whether the survival benefit of cytoreductive nephrectomy (CN) in
metastatic renal cell carcinoma (mRCC) applies to patients with primary tumor size≤ 4 cm …
metastatic renal cell carcinoma (mRCC) applies to patients with primary tumor size≤ 4 cm …